Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Xtant Medical, a global medical technology company specializing in spinal disorder treatments, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024, in Minneapolis. CEO Sean Browne and CFO Scott Neils will represent the company. The event, featuring over 130 public companies, includes one-on-one and small group meetings. Interested parties can schedule a meeting by contacting Brett Maas or their Craig Hallum representative. Additionally, the company's investor presentation is available on Xtant Medical's investor relations website.
- Participation in a prominent investor conference might increase visibility and attract potential investors.
- Availability of the investor presentation on the company's website enhances transparency and accessibility for investors.
- No direct impact on revenue or immediate financial gain from participation in the conference was mentioned.
BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29 in Minneapolis.
The conference is a multi-industry event featuring more than 130 public companies. The format includes one-on-one and small group meetings. To schedule a meeting with management, please contact Brett Maas at xtnt@haydenir.com or your Craig Hallum representative.
In conjunction with hosting one-on-one and small group meetings with investors, the Company's investor presentation is accessible by visiting the "Investors" section of the Company's website at https://investor.xtantmedical.com/.
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
SOURCE: Xtant Medical Holdings, Inc.
View the original press release on accesswire.com
FAQ
When and where is Xtant Medical participating in the investor conference?
Who from Xtant Medical will attend the Craig-Hallum Investor Conference?
How can I schedule a meeting with Xtant Medical's management at the conference?
Where can I find Xtant Medical's investor presentation?
